Novel CAR T Therapy Is a Ray of Hope in the Treatment of Seriously Ill AML Patients

Scientists discuss and explain the most recent advances in chimeric antigen receptor (CAR) T cell-based therapies targeting acute myeloid leukemia (AML) antigens and review the results of preclinical and clinical trials.